LBTD (Lotus Bio-Technology Development) Marketable Securities: $0.00 Mil (As of Dec. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lotus Bio-Technology Development Marketable Securities?

Lotus Bio-Technology Development LBTD -99.99% Marketable Securities is $0.00 Mil as of Dec. 2017.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Lotus Bio-Technology Development's Marketable Securities for the quarter that ended in Dec. 2017 was $0.00 Mil.

Lotus Bio-Technology Development  (OTCPK:LBTD) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Lotus Bio-Technology Development Marketable Securities Related Terms

Lotus Bio-Technology Development Marketable Securities Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Marketable Securities Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lotus Bio-Technology Development Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Lotus Bio-Technology Development (LBTD) has a Marketable Securities of $0.00 Mil as of Dec. 2017. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's Marketable Securities too high?
Lotus Bio-Technology Development's current Marketable Securities is $0.00 Mil.
How does Lotus Bio-Technology Development's Marketable Securities compare to SNES and CVAT?
Lotus Bio-Technology Development's Marketable Securities of $0.00 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for an Agriculture company?
A good Marketable Securities depends on the Agriculture industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Lotus Bio-Technology Development and its competitors. Lotus Bio-Technology Development's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current Marketable Securities is $0.00 Mil as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.